Defining the Thrombotic Risk in Patients with Myeloproliferative Neoplasms
Defining the Thrombotic Risk in Patients with Myeloproliferative Neoplasms
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Polycythemia vera (PV) and essential thrombocythemia (ET) are two Philadelphia-negative myeloproliferative neoplasms (MPN) associated with an acquired mutation in the
JAK2
tyrosine kinase gene. There is a rare incidence of progression to myelofibrosis and myeloid metaplasia in both disorders, which may or may not precede transformation to acu...
Alternative Titles
Full title
Defining the Thrombotic Risk in Patients with Myeloproliferative Neoplasms
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1973bb4f586b4ae7b9b5dd72cd918ce6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1973bb4f586b4ae7b9b5dd72cd918ce6
Other Identifiers
ISSN
1537-744X,2356-6140
E-ISSN
1537-744X
DOI
10.1100/tsw.2011.108
